Seven years after the last revision in 2015, India has announced its latest national list of essential medicines (NLEM), which covers 384 drugs in total across 27 therapeutic categories and adds 34 therapies, including insulin glargine, teneligliptin, lenalidomide and montelukast, to the roster.
While the primary objective of the NLEM is to promote the rational use of drugs with an eye on cost,...







